Skip to main content
snıff

Australian Shepherd

Australian Shepherd
Photo: Trickdog-Fina / CC BY-SA 3.0 · Wikimedia

31 Australian Shepherds in the atlas. Every number on this page has a source.

Population-genetic snapshot of Australian Shepherds in the Sniff Atlas, source-graded Mendelian carrier frequencies from Donner 2023, and nutrition guidance tied to the genetic findings above.

Also known as Aussie, Australian, Standard Shepherd Dog, and little blue dog.

See in the atlas → From CanVAS
The plain version

Australian Shepherds have a nicely varied genetic background, which is a good thing for the breed's overall health. They typically weigh around 53 lb and live about 14 years, known for their medium size and energetic nature. This breed's gene pool includes some sensitivity to certain medications and a few risks related to heart and spine health, so it’s a good idea to chat with your vet or consider genetic testing to keep your dog safe. Overall, Australian Shepherds are sturdy, smart, and full of life!

What the atlas says about Australian Shepherd

In the atlas, the Australian Shepherd clusters consistently as Australian Shepherd (100% of the 31 dogs here). Genetic diversity is high (mean heterozygosity 0.3612), reflecting either a mixed-breed cluster or breeds with broad genetic backgrounds. At the trait loci, HMGA2 runs lower than average (18% here vs 56%); BMP3 runs higher than the atlas average (98% here vs 66%).

Ranks 94 of 107 on the bottleneck severity scale, in the upper quartile of genetic diversity. Mean heterozygosity is 0.361, notably high, indicates broad genetic background.

Median lifespan is 13.7 years, about 1.9 years longer than a typical dog of 23.85 kg, an unusually positive longevity for this size.

Genetic dimensions · CanVAS atlas

What the genome says about Australian Shepherd

Computed from the 18,477 research dogs in the Atlas.

Dogs in the Atlas
31Founders
20 from Hayward2016, 10 from Spatola, 1 from JenkinsWGS
Genetic diversity
0.36Diverse
Mean heterozygosity across the breed. Ranks 94th most genetically tight of 107 ranked breeds.
What does genetic diversity mean?

How varied a breed's gene pool is — the share of gene spots where a typical dog of the breed carries two different versions rather than two identical ones.

How to read it: Higher = more diverse. Among well-sampled breeds it ranges roughly 0.22 (least diverse) to 0.33 (most diverse).

Diversity is a strength, not a verdict on any individual dog. Lower diversity means it's worth paying attention to recessive-risk testing — not that a dog is doomed.

Cluster structure
Splits into two genetic sub-populations
Intra-breed RMS distance: 24.82 · likely working/show-line, regional, or kennel lineage split.
What does within-breed variation mean?

How much individual dogs within the breed differ from each other genetically.

How to read it: Higher = more internal variety among individuals of the breed.

Sensitive to how many dogs of the breed we've sampled.

Related breeds
In the Herding group
Explore the full lineage map →
VBO foundation stock (breeding records) · AKC breed group
Relatedness is documented lineage + kennel family. Genetic-ancestry distance measures diversity, not kinship, so it isn't used here.
How long they live
13.7years (life expectancy)
95% CI 12.8–14.6 · VetCompass, McMillan 2024, n=224. source
What does typical lifespan mean?

The median age dogs of the breed tend to reach.

How to read it: Higher = longer-lived. Compare to longevity-for-size to see whether it's just a size effect.

Drawn from population lifespan records; individual dogs vary widely with care, genetics, and luck.

Trait genetics
Allele frequencies at named morphology loci

Frequency of the alternate allele in this breed at each locus's representative SNP.

Body size
IGF158%
HMGA218%
SMAD261%
LCORL97%
STC293%
ADAMTS1730%
Leg length
FGF4·CFA1886%
FGF4·CFA1261%
Coat
RSPO246%
FGF594%
KRT7181%
MC1R87%
Ear set
MSRB377%
Skull shape
BMP398%
SMOC258%
n = 31 dogs · moderate confidence · CanVAS (Brundage 2026) · Sniff Atlas
Names & origins

Other names

The Australian Shepherd is also recorded as Aussie, Australian, Standard Shepherd Dog, and little blue dog.

Identified as Australian Shepherd (VBO:0200095) in the Vertebrate Breed Ontology (Mullen et al. 2025, CC-BY 4.0) · registry IDs FCI 342 · iDog 16 · VeNom 22606.

Temperament

What Australian Shepherds tend toward

Tendencies from owner surveys of purebred Australian Shepherds — a leaning across the breed, not a prediction for any one dog. A bar’s strength shows how much of that behavior breed actually explains: for most it’s faint, because the rest is your dog, their training, and the life you give them.

Biddabilitybreed ~18%
biddableindependent
Toy-directed Motor Patternsbreed ~18%
toy-directednot toy-directed
Arousal Levelbreed ~8%
arousedcomposed
Environmental Engagementbreed ~9%
high engagementlow engagement
Agonistic Thresholdbreed ~9%
assertivediffident
Proximity Seekingbreed ~13%
affectionatealoof
Human Sociabilitybreed ~11%
less sociablehighly sociable
Dog Sociabilitybreed ~8%
less sociablehighly sociable
n = 118 dogs · Morrill et al. 2022, Science, Darwin's Ark (CC0)
Owner-reported purebreds; each factor n ≥ 25. "Breed ~%" is the share of this behavior explained by breed.
What you see when you look at a Australian Shepherd

What does the genome say about how a Australian Shepherd looks?

Australian Shepherds look the way they do because of a small set of fixed and near-fixed morphology genes that, taken together, define the visible breed. Each translation below pairs the gene with the trait an owner actually sees, the breed's allele frequency at that locus, and a one-clause causal phrase.

Where the breed-defining genes act, mapped on a generic dog-body key — and how fixed each marker is in the Australian Shepherd. The figure is the most-settled marker we read in that region; the full per-locus panel is below. (The silhouette is a shared anatomical guide, not this breed's outline.)

Body sizeLCORL · 97%Skull shapeBMP3 · 98%EarsMSRB3 · 77%Leg lengthFGF4 CFA18 · 86%Coat & colorFGF5 · 94%
CanVAS trait-locus panel (Brundage 2026)
15 morphology markers read across 5 regions. Allele frequency = how fixed a marker is in this breed, not whether your dog carries it.

Size and build

IGF1 sits at 58% for the small-body allele. IGF1 is the gene that sets dog body size from Chihuahua to Great Dane. Intermediate frequencies typically keep a breed in the mid-sized range rather than tipping toward the larger working forms.

IGF1what this gene does

IGF1 is a gene that plays a key role in determining a dog's body size. It influences how much a dog grows, affecting overall stature.

For your dog: Knowing about IGF1 gives you insight into your dog's size traits, but it’s just one part of the bigger picture when it comes to their health and care.

Full IGF1 gene page →

HMGA2 is at 18%, leaving most of the size signal to other loci in the panel.

HMGA2what this gene does

HMGA2 is a gene that influences body size in dogs, helping determine how big or small a dog grows.

For your dog: Knowing about HMGA2 helps you appreciate the genetic factors behind your dog's size, but it doesn't signal any health issues.

Full HMGA2 gene page →

SMAD2 sits at 61% at the chromosome-7 height locus.

SMAD2what this gene does

SMAD2 is a gene involved in regulating body size by influencing how cells grow and develop.

For your dog: Knowing about SMAD2 helps understand your dog's size traits but isn't linked to health issues; no immediate action needed.

Full SMAD2 gene page →

LCORL is near-fixed at 97%, the NCAPG/LCORL height locus that is one of the strongest single contributors to canine body size.

LCORLwhat this gene does

LCORL is a gene that influences body size in dogs. It helps determine how big or small a dog might grow.

For your dog: Knowing about LCORL helps you appreciate the genetic factors behind your dog's size, but it’s just one piece of the bigger picture when it comes to health and care.

Full LCORL gene page →

STC2 is near-fixed at 93%, modulating growth-axis signaling toward the breed's body-size set point.

ADAMTS17 is at 30%, the lower-frequency allele in this breed.

ADAMTS17what this gene does

ADAMTS17 is a gene that influences body size and also plays a role in certain eye conditions. It affects the structure of tissues in the eye and elsewhere in the body.

For your dog: If your dog belongs to a breed known to carry ADAMTS17 variants, it’s worth discussing genetic testing and eye exams with your vet to stay ahead of potential issues.

Full ADAMTS17 gene page →

Leg length

The FGF4 retrogene on chromosome 18 is near-fixed in this breed at 86%. This is the leg-length variant. The breed is fully committed to the long-legged form rather than the short-legged Corgi-and-Dachshund body plan.

The FGF4 retrogene on chromosome 12 sits at 61%, the chondrodystrophic variant.

Coat type, length, and color

RSPO2 sits at 46% for the furnishings variant. Furnishings (the eyebrow-and-mustache pattern seen in Schnauzers and Wheaten Terriers) vary across the population at this intermediate frequency, and visible expression depends on the specific allele combination each dog carries.

RSPO2what this gene does

RSPO2 influences the texture and appearance of a dog's coat, particularly the presence of 'furnishings' like mustaches and eyebrows. It helps determine whether a dog has that distinctive wiry or textured look.

For your dog: If your dog has those wiry eyebrows or a mustache, RSPO2 is part of the reason—no health worries, just a coat feature worth knowing about.

Full RSPO2 gene page →

FGF5 is at 94% for the long-coat variant, which is why the breed's coat sits where it does on the long end of the dog coat-length spectrum.

FGF5what this gene does

FGF5 is a gene that influences the length of a dog's coat. It acts like a natural switch, telling hair follicles when to stop growing longer fur.

For your dog: If your dog has a notably long or short coat, FGF5 is likely part of the reason—no action needed, but it’s a neat genetic detail to know.

Full FGF5 gene page →

KRT71 sits at 81% for the wavy/curly variant. Coat curl varies across individuals at this intermediate frequency, and visible expression is also influenced by modifier loci.

KRT71what this gene does

KRT71 is a gene that influences the curliness of a dog's coat. It helps determine whether a dog's fur is straight or has a distinctive curl.

For your dog: If your dog has a curly coat, KRT71 is likely part of the reason; it’s a natural variation, not a health concern.

Full KRT71 gene page →

MC1R is at 87% at the representative SNP. MC1R controls the switch between red-to-gold and black-to-brown pigment, with the e/e homozygous genotype producing the gold-to-red spectrum by blocking eumelanin (black and brown pigment).

MC1Rwhat this gene does

MC1R is a gene that influences coat color in dogs, affecting how pigments are produced in the fur.

For your dog: Knowing about MC1R gives insight into your dog's coat color but doesn't relate to health issues.

Full MC1R gene page →

Ears

MSRB3 sits at 77% for the drop-ear allele, which is why ear set varies across the breed.

MSRB3what this gene does

MSRB3 is a gene involved in the development of ear shape and structure in dogs.

For your dog: Understanding MSRB3 helps explain why your dog's ears look the way they do, but it isn't linked to any health issues.

Full MSRB3 gene page →

Skull shape

BMP3 is at 98%, contributing to the breed's brachycephalic skull shape.

BMP3what this gene does

BMP3 is a gene that influences the shape of a dog's skull, particularly contributing to a shorter, broader head shape known as brachycephaly.

For your dog: If your dog has a broad, short skull, it's worth discussing with your vet how this might impact their health, even though BMP3 isn't directly tied to illness.

Full BMP3 gene page →

SMOC2 sits at 58%, contributing to the breed's moderate head shape.

SMOC2what this gene does

SMOC2 influences the shape of a dog's skull, particularly affecting how flat or short the face appears.

For your dog: If your dog has a short nose, it's worth discussing with your vet how this trait might impact their health over time.

Full SMOC2 gene page →
Mendelian-disease genetics

What genetic diseases do Australian Shepherds carry?

From a panel of 250 Mendelian-disease variants screened in 1,054,293 dogs (Donner et al. 2023), Australian Shepherds carry 19 of them at observable frequency. Carrier frequency is not clinical risk. Most recessive variants require two copies for disease expression; many dominant variants show incomplete penetrance. Read this as a population fingerprint of what's in the gene pool, not a per-dog prediction.

MDR1 (Multidrug Resistance 1) Medication Sensitivity
Autosomal dominant
high 24.3%
n = 2,296 dogs · 1 variant tested · OMIA:001402-9615 · omia.org →
ABCB1what this gene does

ABCB1 is a gene that helps control how certain drugs are processed and cleared from a dog's body.

For your dog: If your dog is from a breed that carries this gene variant, ask your vet about medication sensitivities before giving any new drugs.

Dilated Cardiomyopathy risk factor (Discovered in the Doberman Pinscher; PDK4-related)
Autosomal dominant (Incomplete penetrance)
high 11.5%
n = 2,296 dogs · 2 variants tested · OMIA:000162-9615 · omia.org →
PDK4what this gene does

PDK4 helps regulate how cells use energy, especially in the heart muscle.

For your dog: If your dog is one of the breeds known to carry this gene, it’s worth discussing heart health with your vet, but being a carrier doesn’t mean your dog will develop disease.

Chondrodystrophy and Intervertebral Disc Disease Risk (CDDY)
Autosomal dominant
moderate 2.3%
n = 2,290 dogs · 1 variant tested · OMIA:000157-9615 · omia.org →
FGF4what this gene does

FGF4 influences leg length by affecting bone growth, leading to shorter legs in certain breeds.

For your dog: If your dog is from a breed known to carry this gene, it's worth discussing spinal health with your vet, but being a carrier doesn’t guarantee problems.

Degenerative Myelopathy (DM)
Autosomal recessive (Incomplete penetrance)
low 9.0%
n = 2,296 dogs · 1 variant tested · OMIA:000263-9615 · omia.org →
SOD1what this gene does

SOD1 is a gene that helps protect cells from damage caused by harmful molecules called free radicals.

For your dog: If your dog is a carrier of SOD1 variants, it's worth discussing with your vet, but remember carrier status doesn't mean your dog will get the disease.

Collie Eye Anomaly (CEA)
Autosomal recessive
low 5.0%
n = 2,296 dogs · 1 variant tested · OMIA:000218-9615 · omia.org →
NHEJ1what this gene does

NHEJ1 is a gene involved in repairing breaks in DNA, helping maintain the integrity of genetic information in cells.

For your dog: If your dog belongs to one of the breeds known to carry this gene variant, it's worth discussing testing with your vet to understand any potential eye health risks.

Hyperuricosuria (HUU)
Autosomal recessive
low 3.1%
n = 2,296 dogs · 1 variant tested · OMIA:001033-9615 · omia.org →
SLC2A9what this gene does

SLC2A9 is a gene that helps regulate uric acid levels in a dog's body. It plays a role in how the kidneys handle this substance.

For your dog: If your dog is one of the breeds known to carry this gene variant, it’s worth discussing with your vet to understand any potential urinary health concerns.

Cone-Rod Dystrophy (cord1-PRA/crd4)
Autosomal recessive (Incomplete penetrance)
low 1.6%
n = 2,291 dogs · 1 variant tested · OMIA:001432-9615 · omia.org →
RPGRIP1what this gene does

RPGRIP1 is a gene involved in the function of photoreceptor cells in the eye, which help dogs see in different light conditions.

For your dog: If your dog belongs to a breed known to carry RPGRIP1 mutations, it’s worth discussing with your vet to understand the risks and monitor eye health.

Von Willebrand's Disease, Type 1 (vWD 1)
Autosomal recessive
low 0.59%
n = 2,296 dogs · 1 variant tested · OMIA:001057-9615 · omia.org →
Progressive Rod-Cone Degeneration (prcd-PRA)
Autosomal recessive
low 0.37%
n = 2,293 dogs · 1 variant tested · OMIA:001298-9615 · omia.org →
PRCDwhat this gene does

PRCD is a gene involved in the health of a dog's retina, the part of the eye that detects light and helps with vision.

For your dog: If your dog belongs to a breed known to carry PRCD changes, it's worth discussing eye health and potential genetic testing with your vet.

Canine Multifocal Retinopathy 1 (Discovered in Mastiff-related breeds; CMR1)
Autosomal recessive
low 0.37%
n = 2,296 dogs · 1 variant tested · OMIA:001444-9615 · omia.org →
BEST1what this gene does

BEST1 is a gene that helps maintain the health of the retina, the light-sensitive layer at the back of the eye. It plays a role in keeping the cells in the retina functioning properly.

For your dog: If your dog is from a breed known to carry BEST1 variants, it’s worth discussing retinal health with your vet, especially if you notice any vision changes.

Neuronal Ceroid Lipofuscinosis 8 (Discovered in the Australian Shepherd; NCL8)
Autosomal recessive
low 0.17%
n = 2,296 dogs · 3 variants tested · OMIA:001506-9615 · omia.org →
Cystinuria Type I-B (SLC7A9 p.A217T)
Autosomal recessive (Incomplete penetrance)
low <0.1%
n = 2,296 dogs · 2 variants tested · OMIA:001880-9615 · omia.org →
SLC7A9what this gene does

SLC7A9 is a gene that helps transport certain amino acids in the kidneys. It plays a role in how the body handles cystine, an amino acid that can form crystals.

For your dog: If your dog is a carrier, it’s worth discussing with your vet to monitor urinary health and catch any issues early.

Cystinuria Type I-A (SLC3A1 p.I192V)
Autosomal recessive
low <0.1%
n = 2,296 dogs · 3 variants tested · OMIA:000256-9615 · omia.org →
SLC3A1what this gene does

SLC3A1 is a gene that helps transport certain amino acids in the kidneys. It plays a key role in preventing the buildup of cystine, which can form stones.

For your dog: If your dog is from a breed known to carry SLC3A1 variants, it’s worth discussing cystinuria risks with your vet, especially if urinary issues arise.

Dilated Cardiomyopathy (Discovered in the Schnauzer; DCM)
Autosomal recessive
low <0.1%
n = 2,296 dogs · 1 variant tested · OMIA:002365-9615 · omia.org →
RBM20what this gene does

RBM20 is a gene that helps control how the heart muscle builds and repairs itself. It plays a key role in keeping the heart's pumping function strong.

For your dog: If you have a dog from these breeds, it’s worth discussing heart health with your vet, especially as your dog ages.

Factor VII Deficiency
Autosomal recessive
low <0.1%
n = 2,296 dogs · 1 variant tested · OMIA:000361-9615 · omia.org →
F7what this gene does

The F7 gene helps produce a protein important for blood clotting, which stops bleeding when dogs get injured.

For your dog: If your dog is from a breed known to carry F7 variants, it's worth mentioning to your vet before any surgery or if you notice unusual bleeding.

Intestinal Cobalamin Malabsorption (Discovered in the Border Collie; CUBN-related)
Autosomal recessive
low <0.1%
n = 2,296 dogs · 3 variants tested · OMIA:001786-9615 · omia.org →
CUBNwhat this gene does

The CUBN gene helps the body absorb vitamin B12 from the intestines, which is essential for energy and nerve function.

For your dog: If your dog’s breed is on the list, it’s worth discussing CUBN-related risks with your vet to keep an eye on their vitamin B12 levels.

Craniomandibular Osteopathy (Discovered in the Cairn, Scottish and West Highland White Terrier)
Autosomal dominant (Incomplete penetrance)
low <0.1%
n = 2,296 dogs · 1 variant tested · OMIA:002244-9615 · omia.org →
SLC37A2what this gene does

SLC37A2 is a gene involved in how cells manage certain sugar molecules, which can affect bone development.

For your dog: If your dog is from a breed known to carry this gene variant, it's worth discussing with your vet, especially if you notice jaw discomfort or eating issues.

Early-Onset Progressive Polyneuropathy (Discovered in the Greyhound)
Autosomal recessive
low <0.1%
n = 2,296 dogs · 2 variants tested · OMIA:002120-9615 · omia.org →
NDRG1what this gene does

NDRG1 is a gene involved in nerve cell function and maintenance, helping keep the nervous system working properly.

For your dog: If your dog is from a breed known to carry NDRG1 variants, it’s worth discussing with your vet, especially if you notice any mobility issues.

Pituitary-Dependent Hyperadrenocorticism (Discovered in Poodles)
Autosomal dominant
low <0.1%
n = 2,296 dogs · 1 variant tested · OMIA:000247-9615 · omia.org →
Source: Donner J et al. 2023. Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651 · Evidence: Limited (DTC ascertainment, tag-SNP proxy) · Confounding MEDIUM · License CC-BY-4.0 · Phene IDs from OMIA (Sydney School of Veterinary Science, The University of Sydney; DOI 10.25910/2AMR-PV70).
Sample size in this breed: 2,296 dogs from the Donner 2023 cohort.

Which Mendelian variants matter most for Australian Shepherds?

The Mendelian-disease table above lists variants screened in 2,296 Australian Shepherds (Donner 2023). Two matter most by carrier frequency and clinical impact.

Medication Sensitivity (MDR1)

Medication sensitivity in Australian Shepherds is an autosomal-dominant condition caused by a loss-of-function variant in MDR1. The gene encodes a drug transporter in the blood-brain barrier. Dogs with one or two copies cannot clear certain drugs efficiently, and those drugs accumulate to toxic levels in the brain. The drugs that cause clinical toxicity are most commonly ivermectin (used for parasite prevention) and moxidectin, but the list extends to some anti-cancer drugs and a few others. About 24.3% of Australian Shepherds in the Donner cohort carry the variant (n=2,296).

Clinical signs of toxicity include tremor, ataxia, blindness, and seizure. Onset is rapid after exposure to a triggering drug. The condition is not a death sentence if the dog is identified and the triggering drug is withdrawn, but an owner who doesn’t know their dog carries the variant can face an emergency. Testing is widely available. The MDR1 test is one of the highest-yield disease-specific tests for any herding breed.

Dilated cardiomyopathy risk factor in Australian Shepherds is an autosomal-dominant variant with incomplete penetrance. The variant was originally discovered in Doberman Pinschers. The causal gene recorded in this breed is TTN (titin), with PDK4 as an earlier candidate name still used in some commercial tests. Affected dogs develop progressive left-ventricular dilation and reduced ejection fraction. Not every dog with one copy develops clinical disease, which is why the penetrance is marked incomplete. About 11.5% of Australian Shepherds in the Donner cohort carry the variant (n=2,296).

Testing is available through commercial DNA labs. Carriers should have baseline cardiac screening (echocardiography) and periodic re-screening to catch progression early.

Chondrodystrophy and Intervertebral Disc Disease Risk (CDDY)

Chondrodystrophy and intervertebral disc disease risk in Australian Shepherds is caused by a high-frequency FGF4 retrogene duplication. The variant is present in 2.3% of Australian Shepherds in the Donner cohort (n=2,290). Australian Shepherds do not show the shortened-limb phenotype of classically chondrodystrophic breeds like Dachshunds; the breed standard shows normal leg length. Australian Shepherds carrying the CDDY variant face elevated intervertebral disc disease risk. Clinical expression varies; not every carrier develops a disc event, but the risk is meaningfully higher than in non-carriers. Testing exists and is useful for carrier-awareness in breeding decisions.

Degenerative Myelopathy (DM)

Degenerative myelopathy in Australian Shepherds is an autosomal-recessive, progressive spinal-cord degeneration. Affected dogs develop rear-limb weakness and loss of muscle tone, usually in middle to late life. About 9.0% of Australian Shepherds in the Donner cohort carry one copy of the variant (n=2,296). The incomplete penetrance means not every dog with two copies becomes symptomatic, though clinical presentation in affected dogs is consistent.

Testing is available. Carriers should be aware of the variant in breeding decisions.

How should I test my Australian Shepherd?

The high-yield testing panel for Australian Shepherds is MDR1 (medication sensitivity), PDK4-related DCM, CDDY (chondrodystrophy/IVDD), DM (degenerative myelopathy), CEA (Collie eye anomaly), and HUU (hyperuricosuria). For breeding stock, all variants in the table above should be part of the screening conversation.

What should I feed an Australian Shepherd?

Australian Shepherds are working dogs with metabolisms tuned for full-day stockwork. A pet Australian Shepherd eating a maintenance kibble in a suburban yard is being fed for a job they aren’t doing. The breed’s known genetic vulnerabilities, cardiac risk at 11.5% carrier frequency for the TTN-based DCM risk variant, IVDD risk from the 2.3% CDDY carriers, and 24.3% MDR1 carriers who cannot metabolize certain ingredients, mean food composition matters.

Joint and spine health starts with growth rate. A large-breed puppy formulation with controlled calcium (0.8 to 1.2% dry matter) and a calcium-to-phosphorus ratio between 1.1:1 and 2:1 is the right starting point (NRC 2006). Australian Shepherds reach adult weight faster than most large breeds, and over-supplementation of calcium during growth is a documented risk factor for developmental orthopaedic disease (NRC 2006). Adult-life weight management is the other half. An overweight Australian Shepherd carrying the CDDY variant faces higher IVDD risk; an overweight dog with the cardiac variant faces hemodynamic stress. The food bowl is where weight control begins.

Cardiac health benefits from taurine-sufficient formulations. Taurine is a semi-essential amino acid, meaning healthy dogs can synthesize it, but synthesis can be outpaced by demand in certain contexts. The breed’s 11.5% carrier frequency for the TTN-based DCM risk variant is not a guarantee of disease, but it is a signal to avoid grain-free diets heavy in pulse ingredients (peas, lentils, chickpeas) that may correlate with taurine bioavailability issues. The FDA’s 2018 advisory and Adin et al. 2019 (JVIM) documented diet-associated DCM in breeds with high genetic risk. Grain-inclusive, taurine-supplemented adult formulations remain the conservative default for this breed.

MDR1 carriers cannot clear certain drugs, which extends to some nutritional supplements. The 24.3% MDR1 carrier frequency means roughly one in four Australian Shepherds in the general population carries the variant. An owner using a supplement containing ivermectin (rare in food, common in certain over-the-counter parasite preventatives) or moxidectin could inadvertently trigger toxicity in a carrier dog. Food-based parasite prevention is not a practical workaround; the real workaround is testing. Know whether your dog carries MDR1 before you choose a parasite-prevention strategy.

All life stages benefit from consistent feeding frequency and portion control. Australian Shepherds are food-motivated and metabolically responsive; free-feeding is the common path to overweight.

What we don’t know

The Australian Shepherd atlas contains only 31 dogs, which is small for the breed’s real-world population. That sample size limits the precision of lifespan estimates and rules out sub-breed analysis. The median lifespan of 13.7 years is consistent with the range cited by the Australian Shepherd Club of America health program (asca.org), but longevity outliers and their genetic correlates are not well-resolved in this cohort.

The penetrance of the TTN-based DCM risk variant in Australian Shepherds is unknown. The variant was first characterized in Doberman Pinschers, where it shows higher clinical penetrance. We do not yet know what proportion of Australian Shepherd carriers develop symptomatic disease, at what age, or what environmental modifiers (diet, exercise, genetics at other loci) influence progression.

The CEA and cone-rod dystrophy variants are at low frequency (5.0% and 1.6% carrier frequency, respectively) but represent real disease risk. Published environmental analyses for these conditions in Australian Shepherds specifically are sparse; the breed-club health programs focus on test-before-breeding rather than longitudinal natural-history tracking.

Frequently asked questions about Australian Shepherds

Are Australian Shepherds prone to heart disease? The breed carries a TTN-based dilated cardiomyopathy risk variant at 11.5% carrier frequency (Donner 2023, n=2,296). Not every carrier develops clinical disease due to incomplete penetrance. Cardiac screening is recommended for carriers and dogs with family history.

What is the most common genetic disease in Australian Shepherds? Medication sensitivity from the MDR1 variant. 24.3% of Australian Shepherds carry the mutation (Donner 2023, n=2,296). It is not a disease itself but a pharmacogenetic risk, dogs with the variant cannot tolerate certain parasite preventatives and some other drugs.

Should I do a DNA test on my Australian Shepherd? For breeding stock, yes. The minimum panel should include MDR1, PDK4-related DCM, CDDY, and DM. If you use any parasite prevention containing ivermectin or moxidectin, MDR1 testing is essential even for pet dogs.

What is intervertebral disc disease and does it affect Australian Shepherds? Intervertebral disc disease (IVDD) is acute or chronic spinal-cord compression from disc herniation. Australian Shepherds carrying the CDDY variant (2.3% of the breed, Donner 2023) face elevated IVDD risk, with clinical onset most commonly reported in mid-life. Weight management and avoiding high-impact jumping reduce symptom severity.

How long do Australian Shepherds live? The atlas-derived median lifespan for Australian Shepherds is 13.7 years. Breed-club estimates from the Australian Shepherd Club of America (asca.org) are consistent with this range. Individual lifespan depends on genetics, health screening, and management.

What parasite prevention is safe for Australian Shepherds? MDR1 carriers (24.3% of the breed) cannot tolerate ivermectin or moxidectin. If your dog carries the variant, your veterinarian can recommend safe alternatives. A DNA test is the fastest way to know your dog’s MDR1 status.

Do Australian Shepherds have vision problems? Two low-frequency variants are linked to vision loss: Collie eye anomaly (5.0% carrier frequency) and cone-rod dystrophy (1.6% carrier frequency). Both are autosomal recessive, so affected dogs are rare. Breeding stock should be tested.

Are Australian Shepherds good with kids? Yes, the breed is well-known for patience and trainability with children. The breed standard and breeding philosophy emphasize temperament. Genetics alone do not determine behavior; early socialization and consistent training matter as much as genetics.

A gift to human medicine

Australian Shepherds are a natural model for human disease

Because the same genes cause the same conditions across species, the inherited conditions documented in Australian Shepherds help researchers understand, and work toward treating, the human diseases they model. This is the dog advancing human medicine. The breed models the human disease; it does not have it, and this is not a prediction for your dog.

Human equivalents via OMIA → Mondo / OMIM. Model-of, not identity.
Documented in OMIA

Every condition recorded in the Australian Shepherd

Beyond the testable carriers above, OMIA's literature catalogue records 22 genetic conditions in the Australian Shepherd, 20 of which have a known human equivalent. This is the documented landscape across all Australian Shepherds ever studied, not a prediction for any one dog.

Plus 4 more conditions recorded in the Australian Shepherd in OMIA.

Online Mendelian Inheritance in Animals (OMIA); Nicholas, Tammen & Sydney Informatics Hub, DOI 10.25910/2AMR-PV70
Documented in the breed's literature is not carrier status and not a forecast for an individual dog. Human equivalents are mapped via Mondo/OMIM. Carrier frequencies (above) are the separately-measured testable subset (Donner 2023).
The data behind this page

Where every number on this page came from.

This page draws on three primary data sources. Carrier frequencies for the Mendelian section come from Donner et al. 2023 (CC-BY-4.0). We grade these data at evidence Limited because the cohort is a direct-to-consumer ascertainment, which biases toward owners who chose to test their dogs. The panel also uses tag-SNP proxies for some variants rather than direct causal-variant assays. Limited is a study-design grade, not a quality grade: the Donner cohort is the largest open canine-genotype dataset in existence and we are grateful for it. We rate the confounding MEDIUM.

Population-genetic dimensions (heterozygosity, intra-breed PCA distance, nearest neighbors, trait-locus frequencies) come from CanVAS (Brundage 2026), harmonized through the Sniff Atlas. The exact release date and verification commit are pinned at the bottom of the page so a researcher can trace a number back to a specific snapshot. The disease-gene-variant graph comes from OMIA (Online Mendelian Inheritance in Animals; Nicholas, Tammen, and the Sydney Informatics Hub at the Sydney School of Veterinary Science, The University of Sydney; retrieved April 2026, DOI 10.25910/2AMR-PV70).

What this page does not yet have. Inheritance modes and per-disease penetrance evidence from Donner 2023 are now in the structured data for every variant the panel covers. Mondo, OMIM, Ensembl, and HGNC cross-references on gene pages remain pending, they arrive in December 2026 alongside the imputed 9.67M-variant CanVAS dataset via the OMIA SQL dump absorption. Until then, gene IDs carry NCBI Gene and OMIA phene URLs only; the wider human-homolog and disease-ontology cross-reference set fills in with that release.

How to cite this page. The computed dimensions on this page are derived from the open Sniff Atlas v1.0.1 (Gehring 2026, doi:10.5281/zenodo.20566358, CC-BY 4.0). Full citation formats including BibTeX, RIS, and CITATION.cff at sniff.world/cite.

Add your australian shepherd to the atlas

We have 31 australian shepherds. We do not have yours.

Every australian shepherd added sharpens the breed's genetic neighborhood. Enrollment is free. The data stays open. The star is permanent.

Add your australian shepherd now as a Charted star
Want to wait for DNA uploads?

Leave your email and we'll let you know the moment DNA uploads open for Australian Shepherds.

References
  1. Donner J, Freyer J, Davison S, Anderson H, Blades M, Honkanen L, et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651. doi:10.1371/journal.pgen.1010651
  2. Brundage J, et al. (2026). CanVAS: a harmonized canine variant atlas. bioRxiv. doi:10.64898/2026.04.13.718238
  3. Nicholas, F.W., Tammen, I., & Sydney Informatics Hub. (2026). Online Mendelian Inheritance in Animals (OMIA) [dataset]. The University of Sydney. https://omia.org. doi:10.25910/2AMR-PV70 (retrieved April 2026).
Last updated
Sources: CanVAS (Brundage 2026) · Donner 2023 · OMIA